JSE:DCP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
JSE:DCP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Dis-Chem Pharmacies Ltd JSE:DCP
Dis-Chem Pharmacies JSE:DCP -0.36% 87 Effective Interest Rate on Debt % is 9.10% as of Feb. 2026. GuruFocus rates JSE:DCP with a GF Score™ of 87/100 and a GF Value™ of R38.34 (Modestly Undervalued). The stock has 4 warning signs investors should review.
Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Dis-Chem Pharmacies's annualized positive value of Interest Expense for the quarter that ended in Feb. 2026 was R550 Mil. Dis-Chem Pharmacies's average total debt for the quarter that ended in Feb. 2026 was R6,042 Mil. Therefore, Dis-Chem Pharmacies's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2026 was 9.10%.
Dis-Chem Pharmacies (JSE:DCP) Effective Interest Rate on Debt % Explanation
Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.
The historical data trend for Dis-Chem Pharmacies's Effective Interest Rate on Debt % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Dis-Chem Pharmacies Annual Data | |||||||||||||||||||||
| Trend | Feb17 | Feb18 | Feb19 | Feb20 | Feb21 | Feb22 | Feb23 | Feb24 | Feb25 | Feb26 | |||||||||||
| Effective Interest Rate on Debt % | Get a 7-Day Free Trial |
|
|
7.25 | 7.81 | 8.74 | 8.71 | 8.61 | |||||||||||||
| Dis-Chem Pharmacies Semi-Annual Data | ||||||||||||||||||||
| Aug16 | Feb17 | Aug17 | Feb18 | Aug18 | Feb19 | Aug19 | Feb20 | Aug20 | Feb21 | Aug21 | Feb22 | Aug22 | Feb23 | Aug23 | Feb24 | Aug24 | Feb25 | Aug25 | Feb26 | |
| Effective Interest Rate on Debt % | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
|
|
|
9.49 | 9.39 | 8.94 | 9.56 | 9.10 | ||
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Effective Interest Rate on Debt % distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's Effective Interest Rate on Debt % falls into.
Dis-Chem Pharmacies's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Feb. 2026 is calculated as
| Effective Interest Rate on Debt % | ||||||
| = | -1 * Interest Expense | / | ( (Total Debt (A: Feb. 2025 ) | + | Total Debt (A: Feb. 2026 )) | / count ) |
| = | -1 * -553.975 | / | ( (6235.345 | + | 6637.531) | / 2 ) |
| = | -1 * -553.975 | / | 6436.438 | |||
| = | 8.61 % |
where
| Total Debt (A: Feb. 2025 ) | |||
| = | Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation |
| = | 3724.733 | + | 2510.612 |
| = | 6235.345 |
| Total Debt (A: Feb. 2026 ) | |||
| = | Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation |
| = | 3757.966 | + | 2879.565 |
| = | 6637.531 |
Dis-Chem Pharmacies's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2026 is calculated as
| Effective Interest Rate on Debt % | ||||||
| = | -1 * Interest Expense | / | ( (Total Debt (Q: Aug. 2025 ) | + | Total Debt (Q: Feb. 2026 )) | / count ) |
| = | -1 * -549.64 | / | ( (5446.398 | + | 6637.531) | / 2 ) |
| = | -1 * -549.64 | / | 6041.9645 | |||
| = | 9.10 % |
where
| Total Debt (Q: Aug. 2025 ) | |||
| = | Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation |
| = | 3711.76 | + | 1734.638 |
| = | 5446.398 |
| Total Debt (Q: Feb. 2026 ) | |||
| = | Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation |
| = | 3757.966 | + | 2879.565 |
| = | 6637.531 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Feb. 2026) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued. The current stock price of R30.19 is trading 21.3% below its estimated GF Value™ of R38.34. GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Effective Interest Rate on Debt % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.